1.
Vestn Ross Akad Med Nauk
; (7): 3-7, 2010.
Artículo
en Ruso
| MEDLINE
| ID: mdl-20799405
RESUMEN
With the growth of rheumatic morbidity the spectrum of medicines for its management needs to be extended. Selected aspects of etiology and clinical course of rheumatic diseases are discussed with reference to prospects of their application for etiopathogenetic therapy.
Asunto(s)
Citocinas/fisiología , Enfermedades Reumáticas/inmunología , Inmunidad Adaptativa , Autoinmunidad , Infecciones Bacterianas/complicaciones , Humanos , Inmunidad Innata , Interferones/fisiología , Interferones/uso terapéutico , Enfermedades Reumáticas/tratamiento farmacológico , Enfermedades Reumáticas/etiología , Virosis/complicaciones
2.
Zh Mikrobiol Epidemiol Immunobiol
; (1): 79-80, 2009.
Artículo
en Ruso
| MEDLINE
| ID: mdl-19338241
RESUMEN
Testing of immunocompromised patients for markers of beta-herpesviruses--human herpesvirus type 6 (HHV-6) and cytomegalovirus (CMV), as well as gamma-herpesvirus--Epstein-Barr virus (EBV), revealed that all mentioned infections are frequently detected, mainlyas mixed infections. Chronic HHV-6 infection was diagnosed in more than half of the patients, whereas markers of acute phase of CMV and EBV infections were detected in 25% and 15% of patients respectively.